8th  DAWN AC User Group Meeting – North America 2014

This year’s Eighth North American DAWN AC User Group meeting was a great success with excellent talks and lots of opportunity for networking and discussing best practice with colleagues.

A big thank you to Massachusetts General Hospital for hosting the event and to all the speakers and delegates who travelled to Boston making it such a success.

Click on the image below to open the DAWN AC User Group Proceedings Document

The topics covered on the day are as follows:

Welcome & Introduction Lynn Oertel, Clinical Nurse Specialist, Anticoagulant Management Service (AMS), Massachusetts General Hospital, Boston Syd Stewart, Managing Director, 4S DAWN Clinical Software, UK

Is there something in the ether?…. Lynn Oertel, Massachusetts General Hospital, Boston

Improvements in patient safety and data flow with DAWN AC interfaces Julie Atay, Anticoagulation Services Manager, Brigham and Women’s Hospital, Boston

Promoting patient safety during transitions of care: known or unknown Diane DeTour, Nurse, Anticoagulation Management Service (AMS), Massachusetts General Hospital, Boston

21st Century Benchmarking Jenny Wood, 4S DAWN Clinical Software, UK

DAWN AC product update Alistair Stewart & Heather Stevenson, 4S DAWN Clinical Software, UK

Using the variability of INRs to indicate the risk of an event in DAWN AC – Variance Growth Rate (VGR) Syd Stewart, 4S DAWN Clinical Software, UK

Integrated peri-procedure anticoagulation Lisa Vaughn, Clinical Manager, Anticoagulation Service, Confluence Health, Wenatchee

The use of telephone reminder calls improves compliance with INR testing Irina Seliverstov, Nurse, Anticoagulation Management Service (AMS), Massachusetts General Hospital, Boston

Pharmacist management of Novel Oral Anticoagulants (NOACs) Jeff Vandemark, Pharmacist, Anticoagulation Services (AS), Scripps Green Hospital, La Jolla

Too much of a good thing – aspirin discontinuation in chronic warfarin users Katie McCool, Supervisor, Clinical Pharmacy Anticoagulation and Anemia Services (CPAAS), Kaiser Permanente Colorado, Aurora

Adverse events intracranial hemorrhage and major bleeding Dr Darlene Elias, MD, Director, Anticoagulation Services, Division of Pulmonary and Critical Care Medicine, Scripps Clinic and Scripps Green Hospital, La Jolla